Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AstraZeneca Crestor Myopathy Seen At Lower Doses; EU Label Approved

Nov 18 2002

• By The Pink Sheet

Related Content

AstraZeneca Crestor Post-NDA Studies Focusing On 40 Mg Dose

Jul 29 2002

Baycol Withdrawal Gives Boost To Pravachol; Will Crestor NDA Be Affected?

Aug 13 2001

AstraZeneca Crestor Plan: Drop 80 Mg, Submit Lower-Dose Data In Q1

Aug 12 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window